"Uricosuric Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma.
| Descriptor ID |
D014528
|
| MeSH Number(s) |
D27.505.954.329.337.900 D27.505.954.613.860
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Uricosuric Agents".
Below are MeSH descriptors whose meaning is more specific than "Uricosuric Agents".
This graph shows the total number of publications written about "Uricosuric Agents" by people in this website by year, and whether "Uricosuric Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Uricosuric Agents" by people in Profiles.
-
2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020 06; 72(6):744-760.
-
Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance. Am J Physiol Heart Circ Physiol. 2014 Feb 15; 306(4):H574-84.
-
Pegloticase for chronic gout. Cochrane Database Syst Rev. 2010 Mar 17; (3):CD008335.
-
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002 Jun; 282(6):F991-7.
-
Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol. 2000; 45(3):259-64.